Stay updated on M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4 instead of Revision: v3.6.3, indicating a minor version update to the page template with no apparent changes to the study data or visible content.
    Difference
    0.1%
    Check dated 2026-07-25T12:32:13.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.2 to v3.6.3, indicating a small interface update. No study record history content appears to be changed.
    Difference
    0.1%
    Check dated 2026-07-03T23:16:54.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The history now displays the latest Revision: v3.6.2 and removes Revision: v3.6.0. This updates the record's revision metadata on the page.
    Difference
    0.1%
    Check dated 2026-06-26T23:00:03.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new version entry v3.6.0 was added to the study history with a note that the study is no longer looking for participants. The previous version (v3.5.5) was removed from the history.
    Difference
    0.3%
    Check dated 2026-06-12T16:30:41.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The revision history now shows the latest version as v3.5.5, replacing the previous v3.5.4 in the record's metadata.
    Difference
    0.1%
    Check dated 2026-06-05T13:27:28.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.4) was added to the record history and a previous revision (v3.5.3) was removed, indicating a minor update to the page's revision-tracking rather than to the study data.
    Difference
    0.1%
    Check dated 2026-05-15T09:18:52.000Z thumbnail image

Stay in the know with updates to M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.